Results 101 to 110 of about 4,202 (211)

Mechanisms in secondary hypogammaglobulinaemia.

Journal of Clinical Pathology, 1979
Hypogammaglobulinaemia refers to the low levels of circulating antibodies associated with a decreased gammaglobulin zone on electrophoresis. Since IgG is the predominant immunoglobulin a deficiency of it will most readily affect the gammaglobulin zone. Deficiencies of IgA and IgM will not necessarily result in a visual decrease in the latter.
P G, Riches, J R, Hobbs
openaire   +3 more sources

X-linked Hyper IgM (HIGM1) in an African kindred: the first report from South Africa

BMC Pediatrics, 2003
Background The objective of this study was to describe the clinical and molecular features of the first South African family with X-linked hyper-IgM syndrome (HIGM1).
Henderson Howard E, Hughes Jane, Eley Brian S, Pienaar Sandra   +3 more
doaj   +1 more source

Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? [PDF]

, 2014
Diffuse panbronchiolitis (DPB) is an idiopathic inflammatory disease that seems to have an immunological pathogenesis and that causes a severe progressive suppurative and obstructive respiratory disorder.
Barone, Aurora, Bennett, David, Butorano, Marie Aimée Gloria Munezero, Fossi, Antonella, Ginori, Alessandro, Mastrogiulio, Maria Grazia, Rottoli, Paola, Spina, Donatella   +7 more
core   +2 more sources

Congenital Idiopathic Hypogammaglobulinaemia [PDF]

Archives of Disease in Childhood, 1957
K M, PEARCE, M S, PERINPANAYAGAM
openaire   +2 more sources

Differences in adverse events between manuscript and drug labels for myeloma T‐cell‐redirecting therapies

British Journal of Haematology, Volume 207, Issue 4, Page 1659-1663, October 2025.
Bita Bashy, Darshi Shah, David Steensma, Oliver Van Oekelen, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin   +5 more
wiley   +1 more source

Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency

Allergy, Asthma & Clinical Immunology, 2018
Background Daclizumab is a humanized monoclonal antibody that blocks CD25, the high affinity alpha subunit of the interleukin-2 receptor. Daclizumab therapy targets T regulatory cell and activated effector T cell proliferation to suppress autoimmune ...
Leisa Rebecca Watson, Charlotte A. Slade, Samar Ojaimi, Sara Barnes, Pasquale Fedele, Prudence Smith, Justine Marum, Sebastian Lunke, Zornitza Stark, Matthew F. Hunter, Vanessa L. Bryant, Michael Sze Yuan Low   +11 more
doaj   +1 more source

Cracking the BAFF code. [PDF]

, 2009
The tumour necrosis factor (TNF) family members B cell activating factor (BAFF) and APRIL (a proliferation-inducing ligand) are crucial survival factors for peripheral B cells.
A Geffroy-Luseau, A Kato, A Marshak-Rothstein, A Matsuzawa, A Meyer-Bahlburg, A Munafo, A Patke, B He, B Huard, BD Hondowicz, BN Teague, BP O'Connor, C Bossen, C Bossen, C Ding, C Kern, CA Fletcher, CC Goodnow, D Ait-Azzouzene, D Allman, D Bischof, D Sakurai, D Sakurai, DL Langat, E Belnoue, E Castigli, E Castigli, E Gaudin, E Varfolomeev, ES Day, EV Acosta-Rodriguez, F Mackay, F Mackay, F Mackay, F Mackay, F Mackay, Fabienne Mackay, FC Kimberley, G Alsaleh, G Hardenberg, G Liao, GT Mantchev, H Wardemann, H Ye, J Hendriks, J Schwaller, JB Carey, JC Massacand, JE Crowley, JE Stadanlick, JL Scholz, JM Wang, JO Pers, JR Darce, JR Groom, JR Mills, JT Opferman, JT Opferman, K Ingold, KP Baker, KP Lam, L Garibyan, L Gorelik, L Gorelik, L Wen, L-G Xu, LA Sitailo, LG Ng, LG Ng, LS Treml, M Abe, M Batten, M Carbonatto, M Ittah, M Krumbholz, M Krumbholz, M Rizzi, M Thangarajh, M Thien, M Yang, MJ Benson, MW Boule, N Katsenelson, P Bouillet, P Scapini, P Xie, Pascal Schneider, R Lesley, RA Herlands, RJ Grumont, RR Hardy, RT Woodland, RW Hoffman, S Gardam, S Pillai, S Pillai, S Shulga-Morskaya, S Vallabhapurapu, SG Hymowitz, SG Tangye, SK Chang, SK Chang, SL Hauser, SM Anderson, SR Dillon, T Enzler, U Maurer, U Salzer, U Salzer, V Baud, V Pelekanou, VT Chu, X Li, Y Liu, Y Shimomura, Y Vugmeyster   +115 more
core   +1 more source

Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis [PDF]

, 1995
We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow ...
Alzina, V. (Valentín), Azcona-San-Julian, M.C. (María Cristina), Barona, P. (Pascual), Sierrasesumaga, L. (Luis), Villa-Elizaga, I. (Ignacio)   +4 more
core  

Azurophilic inclusions in plasma cells [PDF]

, 2009
We report a 45-year-old man with complaints of chest pain and weight loss who was referred for a bone marrow/trephine procedure to the Aga Khan University Hospital.
Ali, N., Moiz, B.
core  

Common variable immunodeficiency. Epidemiology and clinical manifestations in 69 patients. [PDF]

, 2013
La inmunodeficiencia común variable (IDCV) se caracteriza por una alteración en la producción de anticuerpos y una mayor susceptibilidad a infecciones por bacterias extracelulares capsuladas, principalmente del tracto respiratorio.
Fernández Romero, Diego S., Juri, María C., Malbran, Alejandro, Paolini, María V.   +3 more
core   +1 more source